Your browser doesn't support javascript.
loading
Cannabis use in early adolescence: Evidence of amygdala hypersensitivity to signals of threat.
Spechler, Philip A; Orr, Catherine A; Chaarani, Bader; Kan, Kees-Jan; Mackey, Scott; Morton, Aaron; Snowe, Mitchell P; Hudson, Kelsey E; Althoff, Robert R; Higgins, Stephen T; Cattrell, Anna; Flor, Herta; Nees, Frauke; Banaschewski, Tobias; Bokde, Arun L W; Whelan, Robert; Büchel, Christian; Bromberg, Uli; Conrod, Patricia; Frouin, Vincent; Papadopoulos, Dimitri; Gallinat, Jurgen; Heinz, Andreas; Walter, Henrik; Ittermann, Bernd; Gowland, Penny; Paus, Tomás; Poustka, Luise; Martinot, Jean-Luc; Artiges, Eric; Smolka, Michael N; Schumann, Gunter; Garavan, Hugh.
Afiliação
  • Spechler PA; Vermont Center on Behavior and Health, Departments of Psychiatry and Psychology, University of Vermont, Burlington, VT 05401, United States. Electronic address: philip.spechler@uvm.edu.
  • Orr CA; Vermont Center for Children, Youth, and Families, University of Vermont, Burlington, VT 05401, United States.
  • Chaarani B; Vermont Center on Behavior and Health, Departments of Psychiatry and Psychology, University of Vermont, Burlington, VT 05401, United States.
  • Kan KJ; Vermont Center on Behavior and Health, Departments of Psychiatry and Psychology, University of Vermont, Burlington, VT 05401, United States.
  • Mackey S; Vermont Center on Behavior and Health, Departments of Psychiatry and Psychology, University of Vermont, Burlington, VT 05401, United States.
  • Morton A; Vermont Center on Behavior and Health, Departments of Psychiatry and Psychology, University of Vermont, Burlington, VT 05401, United States.
  • Snowe MP; Vermont Center on Behavior and Health, Departments of Psychiatry and Psychology, University of Vermont, Burlington, VT 05401, United States.
  • Hudson KE; Vermont Center on Behavior and Health, Departments of Psychiatry and Psychology, University of Vermont, Burlington, VT 05401, United States.
  • Althoff RR; Vermont Center on Behavior and Health, Departments of Psychiatry and Psychology, University of Vermont, Burlington, VT 05401, United States.
  • Higgins ST; Vermont Center on Behavior and Health, Departments of Psychiatry and Psychology, University of Vermont, Burlington, VT 05401, United States.
  • Cattrell A; Institute of Psychiatry, King's College London, United Kingdom; Medical Research Council - Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Kings College London, De Crespigny Park, London, United Kingdom.
  • Flor H; Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Square J5, Mannheim, Germany.
  • Nees F; Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neurosciences, Trinity College Dublin, Ireland.
  • Banaschewski T; Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Square J5, Mannheim, Germany.
  • Bokde ALW; Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neurosciences, Trinity College Dublin, Ireland.
  • Whelan R; Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neurosciences, Trinity College Dublin, Ireland.
  • Büchel C; University Medical Centre Hamburg-Eppendorf, Haus S10, Martinistr. 52, Hamburg, Germany.
  • Bromberg U; Department of Psychiatry, Universite de Montreal, CHU Ste Justine Hospital, Canada.
  • Conrod P; Institute of Psychiatry, King's College London, United Kingdom; Department of Psychiatry, Universite de Montreal, CHU Ste Justine Hospital, Canada.
  • Frouin V; Neurospin, Commissariat à l'Energie Atomique, CEA-Saclay Center, Paris, France.
  • Papadopoulos D; Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf (UKE), Martinistrasse 52, 20246 Hamburg, Germany.
  • Gallinat J; Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf (UKE), Martinistrasse 52, 20246 Hamburg, Germany.
  • Heinz A; Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité, Universitätsmedizin Berlin, Charitéplatz 1, Berlin, Germany.
  • Walter H; Physikalisch-Technische Bundesanstalt, Abbestr. 2-12, Berlin, Germany.
  • Ittermann B; Physikalisch-Technische Bundesanstalt, Abbestr. 2-12, Berlin, Germany.
  • Gowland P; School of Psychology, University of Nottingham, University Park, Nottingham, United Kingdom.
  • Paus T; Rotman Research Institute, Baycrest and Departments of Psychology and Psychiatry, University of Toronto, Toronto, Ontario M6A 2E1, Canada.
  • Poustka L; Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neurosciences, Trinity College Dublin, Ireland.
  • Martinot JL; Institut National de la Sante et de la Recherche Medicale, INSERM CEAUnit1000, "Imaging & Psychiatry", University Paris Sud, 91400 Orsay, France.
  • Artiges E; Rotman Research Institute, Baycrest and Departments of Psychology and Psychiatry, University of Toronto, Toronto, Ontario M6A 2E1, Canada.
  • Smolka MN; Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany.
  • Schumann G; Institute of Psychiatry, King's College London, United Kingdom; Medical Research Council - Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Kings College London, De Crespigny Park, London, United Kingdom.
  • Garavan H; Vermont Center on Behavior and Health, Departments of Psychiatry and Psychology, University of Vermont, Burlington, VT 05401, United States.
Dev Cogn Neurosci ; 16: 63-70, 2015 Dec.
Article em En | MEDLINE | ID: mdl-26347227

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Abuso de Maconha / Medo / Tonsila do Cerebelo Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Abuso de Maconha / Medo / Tonsila do Cerebelo Idioma: En Ano de publicação: 2015 Tipo de documento: Article